Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 08-2012 | 08-2011 | 08-2010 | 12-2006 | 12-2005 | |
| Sales | 5,371 | 6,616 | 6,614 | 0 | 0 |
| Cost of Goods | 2,384 | 2,492 | 2,946 | N/A | N/A |
| Gross Profit | 2,987 | 4,124 | 3,668 | N/A | N/A |
| Operating Expenses | 32,173 | 29,514 | 26,850 | 0 | 0 |
| Operating Income | -28,802 | -24,898 | -22,236 | N/A | N/A |
| Interest Expense | 560 | 456 | 153 | 0 | 0 |
| Other Income | -45 | -11,013 | -129 | 0 | 0 |
| Pre-tax Income | -29,407 | -36,367 | -22,518 | 0 | 0 |
| Income Tax | 3 | -31 | 65 | N/A | N/A |
| Net Income Continuous | -29,410 | -36,336 | -22,583 | N/A | N/A |
| Net Income | $-29,410 | $-36,336 | $-22,583 | $N/A | $N/A |
| EPS Basic Total Ops | -17.44 | -146.72 | -93.60 | N/A | N/A |
| EPS Basic Continuous Ops | -17.44 | -146.69 | -93.59 | N/A | N/A |
| EPS Diluted Total Ops | -17.44 | -146.72 | -93.60 | N/A | N/A |
| EPS Diluted Continuous Ops | -17.44 | -146.69 | -93.59 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -17.44 | -146.72 | N/A | N/A | N/A |
| EBITDA(a) | $-26,743 | $-22,823 | $-19,816 | $N/A | $N/A |